• Storify: Should Whole Genome Sequencing Be the Standard for Rare Disease?

    Nov 2, 2015, 13:55 PM by Michael Croft
    Bio-IT World | Elizabeth Worthey's comment that families affected by rare disease should push for whole genome sequencing has bioinformatics Twitter abuzz today, with a passionate and detailed debate about the best use of healthcare resources in the pursuit of a genetic diagnosis.
    Full story
  • Tute Genomics Acquires Knome

    Nov 2, 2015, 11:32 AM by Michael Croft
    PROVO, UT - Nov 2, 2015 -   Tute Genomics, the leader in clinical sequencing informatics, today announced the acquisition of key assets of Knome, a renowned human-genome interpretation company whose systems and services helped spearhead several of the greatest commercial advancements in modern human genetics
    Full story
  • End of the Line for Knome with Acquisition by Tute Genomics

    Nov 2, 2015, 10:10 AM by Michael Croft
    Xconomy | After eight years, more than $20 million raised, and an assortment of different business plans, Massachusetts genomics firm Knome has been acquired by tiny Tute Genomics of Utah.
    Full story
  • FDA Equips its Pharmacometrics Teams with Certara’s Phoenix Software

    Nov 2, 2015, 03:55 AM by Michael Croft
    PRINCETON, NJ, USA - Nov 2, 2015 - Certara®, the global biosimulation technology-enabled drug development company, today announced that the United States Food and Drug Administration (FDA) has outfitted its pharmacometrics teams with Certara’s Phoenix® software
    Full story
  • October News and Product Briefs

    Oct 30, 2015, 13:15 PM by Michael Croft
    Bio-IT World | News and product releases from around the industry, including a CDC test of the Edico DRAGEN processor and new CRISPR partnerships.
    Full story
  • A Moore’s Law Mystery

    Oct 30, 2015, 09:20 AM by Michael Croft
    The Last Word On Nothing | Was Moore's Law originally developed as a marketing ploy for Intel?
    Full story
  • Creative Bioarray Introduces Cryopreserved Mesenteric Cells for Biologists

    Oct 30, 2015, 04:04 AM by Michael Croft
    NEW YORK, NY - Oct 30, 2015 - Creative Bioarray, an innovative biotechnology company who produces the world's most comprehensive list of research-use cells, including tumor cells, primary cells, stem cells and transformed cells, etc, recently announced its new cryopreserved mesenteric cells for researchers, aiming to provide customers more tools for scientific study
    Full story
  • Direct Genomics' New Clinical Sequencer Revives a Forgotten DNA Technology

    Oct 29, 2015, 13:00 PM by Michael Croft
    Bio-IT World | At Direct Genomics in Shenzhen, He Jiankui is bringing back the sequencing technology of the defunct Helicos Biosciences to build a new DNA sequencer for the clinic, promising targeted diagnostic tests with minimal sample preparation and low input requirements.
    Full story
  • BGI Retools Complete Genomics Technology for Its New High-Throughput Benchtop Sequencer

    Oct 28, 2015, 16:25 PM by Michael Croft
    Bio-IT World | The BGISEQ-500, using a dramatically reengineered version of Complete Genomics' "DNA nanoball" sequencing, is designed to compete with Illumina's NextSeq instruments on both price and throughput — at least in the Chinese markets where it is being made available next year.
    Full story
  • TGAC Unleashes DRAGEN to Accelerate Genomics Workflows

    Oct 28, 2015, 13:05 PM by Michael Croft
    HPCwire | Accelerating genomics analysis remains one of the toughest challenges in life science research. All manner of optimizations are in use - disk streaming, op
    Full story
  • SwiftStack Announces Version 3.0

    Oct 26, 2015, 17:30 PM by Michael Croft
    Bio-IT World News Brief | Today at the OpenStack Summit in Tokyo, SwiftStack released version 3.0 of its software with new features that extend the benefits of object storage to enterprise applications.
    Full story
  • Bio-IT World Best Practices Call for Entries Open

    Oct 26, 2015, 16:10 PM by Michael Croft
    Bio-IT World Bio-IT World is accepting entries to the 2016 Bio-IT World Best Practices competition. For the past thirteen years, the Bio-IT World Best Practices Awards have highlighted outstanding examples of innovations and partnerships serving as powerful forces for change in the life sciences.
    Full story
  • Vertex and CRISPR Therapeutics Forge Deal on Gene Editing for Rare Disease

    Oct 26, 2015, 10:37 AM by Michael Croft
    Xconomy | In the latest major partnership around gene editing therapies based on CRISPR-Cas9 technology, Vertex is investing $105 million upfront in CRISPR Therapeutics, to support programs in cystic fibrosis and sickle cell disease, among other conditions.
    Full story
  • BC Platforms to Collaborate with Helsinki University Hospital to Apply its Proprietary Genomics Management Platform to Provide Clinical Benefits for Cancer Patients

    Oct 26, 2015, 05:05 AM by Michael Croft
    HELSINKI, FINLAND - Oct 26, 2015 - BC Platforms, a world leader in genomic data management solutions, today announced that it has signed a partnership agreement with Helsinki University Hospital to use its genomic management platform to integrate, analyze and interpret their extensive clinical and genealogy data with next-generation sequencing data to provide innovative, personalized treatment options for breast cancer patients at the hospital
    Full story
  • With Revolocity, Complete Genomics Eyes New Markets for DNA Sequencing

    Oct 23, 2015, 14:40 PM by Michael Croft
    Bio-IT World | Since being purchased by BGI, Complete Genomics has scrapped its sequencing-as-a-service business and shifted to manufacturing instruments. Although its first product, Revolocity, won't make any headway in the established research market, CEO Cliff Reid believes he's getting in on the ground floor of clinical sequencing, with a pitch for large healthcare organizations ready to take a chance on population genomics.
    Full story
  • CSM Held Successful Grand Opening of New Clinical Trial Supply Facility in Malvern with Elected Officials

    Oct 21, 2015, 09:23 AM by Michael Croft
    MALVERN, PA - Oct 21, 2015 - CSM welcomed over 100 attendees to celebrate the opening of its second facility in the Great Valley Corporate Center of Malvern, Pennsylvania
    Full story
  • 23andMe Will Resume Giving Users Health Data

    Oct 21, 2015, 08:50 AM by Michael Croft
    The New York Times | The genetic-testing company stopped providing health information in 2013 after the F.D.A. ordered it to prove the accuracy of results. Now it will provide carrier status for 36 diseases with FDA approval. The carrier status reports are part of the company's new "user experience", which includes more than 60 reports on health, ancestry, wellness, and personal traits and proprietary tools. Existing customers will be transitioned to the new experience as soon as possible, the company said.
    Full story
  • The latest DIY biotech hot spot? The local library.

    Oct 20, 2015, 15:13 PM by Michael Croft
    Washington Post | A public library in San Diego is home to what may be the world's first biotech laboratory-in-a-library.
    Full story
  • A Mystery Machine That Sculpts the Genome

    Oct 20, 2015, 12:20 PM by Michael Croft
    The Atlantic | New evidence from studies of genome folding and predictive models lends strong support to the hypothesis that the cell contains an "extrusion complex," a piece of molecular machinery that shapes genome architecture by forming DNA loops in predictable — and controllable — patterns.
    Full story
  • Cenduit to Lead Panel at 2015 Interactive Response Technologies in Clinical Trials Forum in Philadelphia

    Oct 20, 2015, 12:18 PM by Michael Croft
    DURHAM, NC, UNITED STATES - Oct 20, 2015 - Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, is showcasing its solutions and expertise as the largest interactive response technology (IRT) specialist in the world by leading a panel at CBI’s 2015 Interactive Response Technologies in Clinical Trials Forum
    Full story